248 related articles for article (PubMed ID: 26489816)
21. Mutational Spectrum of CYP24A1 Gene in a Cohort of Italian Patients with Idiopathic Infantile Hypercalcemia.
Gigante M; Santangelo L; Diella S; Caridi G; Argentiero L; D''Alessandro MM; Martino M; Stea ED; Ardissino G; Carbone V; Pepe S; Scrutinio D; Maringhini S; Ghiggeri GM; Grandaliano G; Giordano M; Gesualdo L
Nephron; 2016; 133(3):193-204. PubMed ID: 27394135
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of a recurrent 10.9 kb CYP24A1 deletion in Idiopathic Infantile Hypercalcemia.
Molin A; Nowoczyn M; Coudray N; Ballandone C; Abéguilé G; Mittre H; Richard N; Eckart P; Castanet M; Kottler ML
Eur J Med Genet; 2019 Nov; 62(11):103577. PubMed ID: 30423445
[TBL] [Abstract][Full Text] [Related]
23. Hypercalcemia and CYP24A1 Gene Mutation Diagnosed in the 2nd Trimester of a Twin Pregnancy: A Case Report.
Romašovs A; Jaunozola L; Berga-Švītiņa E; Daneberga Z; Miklaševičs E; Pīrāgs V
Am J Case Rep; 2021 Oct; 22():e931116. PubMed ID: 34662328
[TBL] [Abstract][Full Text] [Related]
24. Mild Idiopathic Infantile Hypercalcemia-Part 1: Biochemical and Genetic Findings.
Lenherr-Taube N; Young EJ; Furman M; Elia Y; Assor E; Chitayat D; Uster T; Kirwin S; Robbins K; Vinette KMB; Daneman A; Marshall CR; Collins C; Thummel K; Sochett E; Levine MA
J Clin Endocrinol Metab; 2021 Sep; 106(10):2915-2937. PubMed ID: 34125233
[TBL] [Abstract][Full Text] [Related]
25. AN INFANT WITH IDIOPATHIC HYPERCALCIURIA AND NEPHROLITHIASIS ASSOCIATED WITH CYP24A1 ENZYME POLYMORPHISM: A CASE REPORT.
Trutin I; Škorić I
Acta Clin Croat; 2022 Feb; 60(3):544-547. PubMed ID: 35282483
[TBL] [Abstract][Full Text] [Related]
26. Overlapping Phenotypes Associated With
Molin A; Lemoine S; Kaufmann M; Breton P; Nowoczyn M; Ballandonne C; Coudray N; Mittre H; Richard N; Ryckwaert A; Lavillaureix A; Jones G; Bacchetta J; Kottler ML
Front Endocrinol (Lausanne); 2021; 12():736240. PubMed ID: 34721296
[TBL] [Abstract][Full Text] [Related]
27. Idiopathic infantile hypercalcemia: mutations in SLC34A1 and CYP24A1 in two siblings and fathers.
Güven A; Konrad M; Schlingmann KP
J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1353-1358. PubMed ID: 32866123
[TBL] [Abstract][Full Text] [Related]
28. A rapid screening of a recurrent CYP24A1 pathogenic variant opens the way to molecular testing for Idiopathic Infantile Hypercalcemia (IIH).
De Paolis E; Minucci A; De Bonis M; Scaglione GL; Gervasoni J; Primiano A; Ferraro PM; Cappellani D; Marcocci C; Gambaro G; Capoluongo E
Clin Chim Acta; 2018 Jul; 482():8-13. PubMed ID: 29574006
[TBL] [Abstract][Full Text] [Related]
29. Presymptomatic diagnosis of CYP24A1-related infantile idiopathic hypercalcemia: A case report.
Mirea AM; Pop RM; Căinap SS; Trifa AP
Eur J Med Genet; 2020 Dec; 63(12):104100. PubMed ID: 33186763
[TBL] [Abstract][Full Text] [Related]
30. A Pediatric Patient with a CYP24A1 Mutation: Four Years of Clinical, Biochemical, and Imaging Follow-Up.
Ertl DA; Raimann A; Csaicsich D; Patsch JM; Laccone F; Haeusler G
Horm Res Paediatr; 2017; 87(3):196-204. PubMed ID: 27798933
[TBL] [Abstract][Full Text] [Related]
31. Vitamin D and Diseases of Mineral Homeostasis: A
St-Arnaud R; Arabian A; Kavame D; Kaufmann M; Jones G
Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956396
[TBL] [Abstract][Full Text] [Related]
32. [A young girl with recurrent calculosis and hypercalcemia].
Di Maio F; Vittori M; Bassi P; Fulignati P; D'Alonzo S; Ferraro PM
G Ital Nefrol; 2018 May; 35(3):. PubMed ID: 29786188
[TBL] [Abstract][Full Text] [Related]
33. Lightwood syndrome revisited with a novel mutation in CYP24 and vitamin D supplement recommendations.
Castanet M; Mallet E; Kottler ML
J Pediatr; 2013 Oct; 163(4):1208-10. PubMed ID: 23768816
[TBL] [Abstract][Full Text] [Related]
34. Genetic Diseases of Vitamin D Metabolizing Enzymes.
Jones G; Kottler ML; Schlingmann KP
Endocrinol Metab Clin North Am; 2017 Dec; 46(4):1095-1117. PubMed ID: 29080636
[TBL] [Abstract][Full Text] [Related]
35. Iatrogenic vitamin D toxicity in an infant--a case report and review of literature.
Ketha H; Wadams H; Lteif A; Singh RJ
J Steroid Biochem Mol Biol; 2015 Apr; 148():14-8. PubMed ID: 25636720
[TBL] [Abstract][Full Text] [Related]
36. CYP24A1 and SLC34A1 Pathogenic Variants Are Uncommon in a Canadian Cohort of Children with Hypercalcemia or Hypercalciuria.
Rousseau-Nepton I; Jones G; Schlingmann K; Kaufmann M; Zuijdwijk CS; Khatchadourian K; Gupta IR; Pacaud D; Pinsk MN; Mokashi A; Nour MA; Alexander RT; Rodd CJ
Horm Res Paediatr; 2021; 94(3-4):124-132. PubMed ID: 34320495
[TBL] [Abstract][Full Text] [Related]
37. Rare cause of life-threatening hypercalcemia in an infant: a case report.
Lefèvre CR; Peltier L; Lokchine A; Ryckewaert A; Moreau C
Ann Biol Clin (Paris); 2022 Sep; 80(5):460-463. PubMed ID: 36453734
[TBL] [Abstract][Full Text] [Related]
38. Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis.
Dinour D; Beckerman P; Ganon L; Tordjman K; Eisenstein Z; Holtzman EJ
J Urol; 2013 Aug; 190(2):552-7. PubMed ID: 23470222
[TBL] [Abstract][Full Text] [Related]
39. LC-MS/MS for Identifying Patients with CYP24A1 Mutations.
Ketha H; Kumar R; Singh RJ
Clin Chem; 2016 Jan; 62(1):236-42. PubMed ID: 26585929
[TBL] [Abstract][Full Text] [Related]
40. Do the Heterozygous Carriers of a CYP24A1 Mutation Display a Different Biochemical Phenotype Than Wild Types?
Brancatella A; Cappellani D; Kaufmann M; Borsari S; Piaggi P; Baldinotti F; Caligo MA; Jones G; Marcocci C; Cetani F
J Clin Endocrinol Metab; 2021 Mar; 106(3):708-717. PubMed ID: 33249478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
